NeuMoDx Molecular, Inc. announced completion of its Series B financing, $21 million, which included investment from Baird Capital, Venture Investors, and existing investor Arboretum Ventures.
“Venture capitalists in Michigan continue to grow in an environment where, in other parts of the country, the industry is contracting,” said a Managing Director of Arboretum Ventures and the outgoing chair of the Michigan Venture Capital Association.